Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Amersham to Buy Controlling Stake in Informatics Firm Cimarron

NEW YORK, May 14 - Amersham Biosciences said today it will acquire a controlling stake in informatics company Cimarron Software.


Amersham also has the option of acquiring all of the Salt Lake City-based company over the next three years, it said.

Jerry Walker, vice president for informatics at Amersham, said that the companies, which have worked together  since 1996, plan to launch Scierra later this year.  The product lets researchers perform tracking and analysis in proteomics, gene-expression analysis, genotyping, and DNA sequencing.


Cimarron employs 60 software designers, programmers, automation engineers, and other scientists, according to Amersham.


Click here for more information.


The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.